Pancreatic adenocarcinoma, TNBC (ER+/HER2- subtype), Bladder cancer with non-muscle invasive and low tumor mutational burden, glioblastomas with highly immunosuppressive TME, low tumor mutational burden. Here, ERBB2 is linked to urinary bladder carcinoma.